However, recent studies by Moldes et al. [42] showed that administration of BQ788 just after middle cerebral artery occlusion potentiated the anti-edema actions of an ETA antagonist, suggesting an involvement of ETB-mediated mechanisms in inducing vasogenic edema after brain ischemia. This evidence concerns the gene EDNRB and brain ischemia.